NKTR Drug delivery Company | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
NKTR Drug delivery Company

An SI Board Since September 2005

Posts	SubjectMarks	Bans	Symbol
507	31	0	NKTR

Emcee: david nordic	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
82	The concept of inhaled insulin has been around for multiple decades. The techno	tuck	-	8/2/2006
81	Check this out. I was scratching my head over this deal, but now it makes sense	tuck	-	8/2/2006
80	Novo Nordisk files suit against Pfizer PrintDisable live quotesRSSDigg itDel.ic	david nordic	-	8/2/2006
79	>>SAN CARLOS, Calif.--(BUSINESS WIRE)--July 26, 2006--Nektar Therapeutics	tuck	-	7/27/2006
78	D., Unless I misread the PR, Hematide is not in NKTR's pipeline, it's i	Ian@SI	-	7/24/2006
77	Hematide(TM) was not listed on the NKTR's pipeline. The cash payment under	david nordic	-	7/24/2006
76	Some good news today on the other fronts with NKTR...Exubera is not the only hor	Arthur Radley	-	7/24/2006
75	Can you point me to these facts? Jon	Robohogs	-	7/24/2006
74	>>Nektar said most of the revenue would be generated by manufacturing.<	david nordic	-	7/23/2006
73	Thanks; anyhow, NKTR/PFE is aiming for Tier 2, and PFE seemed to think the P&	tuck	-	7/23/2006
72	“P and T” = Pharmacy and Therapeutic Committee, the committee that decides which	DewDiligence_on_SI	-	7/23/2006
71	I listened to the PFE CC. They did say that payors seemed interested. Said som	tuck	-	7/23/2006
70	The important thing near to intermediate term, is that last sentence: >>N	tuck	-	7/20/2006
69	Tuck, I can't say anything bad about NKTR as I made a nice profit when it ra	Arthur Radley	-	7/20/2006
68	Apparently all that manufacturing for anticipated new scripts is more than expec	tuck	-	7/20/2006
67	From the PFE PR: >>Exubera, one of the most significant innovations in in	tuck	-	7/20/2006
66	Seems there is some slippage in the launch...PFE announced in today's Q repo	Arthur Radley	-	7/20/2006
65	My wild guess on the day for announcement of the first shipment of Exubera: thi	tuck	-	7/18/2006
64	More recently, poking around on I-Hub, I found on the the thread there an appare	tuck	-	7/17/2006
63	<i>Added to my position just now.</i> Nice snag, looks like you'	Ian@SI	-	7/17/2006
62	Worth a check, I suppose; the market didn't take the BMO report seriously fo	tuck	-	7/17/2006
61	Tuck, If Christine Charest is still the Biotech analyst, she remained a QLT per	Ian@SI	-	7/12/2006
60	Expectations are all over the map. A gal from JP Morgan went to the recent ADA	tuck	-	7/12/2006
59	Tuck..article in this week's BusinessWeek isn't very kind to Exubera....	Arthur Radley	-	7/10/2006
58	Can't find diddly on safety data in rat models (other animals are used, but	tuck	-	7/7/2006

Go to reply# or date (mm/dd/yy):